New chemotherapy approved for advanced breast cancer - Ixempra
The FDA has approved a new type of chemotherapy for the treatment of advanced breast cancer. Marketed by Bristol-Myers Squibb, Ixempra (ixabepilone) is the first of a new class of chemotherapeutic agents called epitholones that target a protein called tubulin, which is necessary for cells to grow and multiply (which they do in a out of control way in cancer). As cancers progress or recur after treatment with one type of chemotherapy, doctors typically give another type of drug with a different mechanism of action hoping to attack the cancer in a new way. The approval of Ixempra provides such a new type of treatment, and it is the first new type of chemotherapy to be approved in many years.
Ixempra is approved for the treatment of metastatic or locally advanced breast cancer in patients who have already received certain other chemotherapy agents and whose cancer has progressed. It is to […]
Original post by admin and weightlossopinions.com
